Hidradenitis suppurativa trials in Poland
7 of 7 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Where
- Bydgoszcz, Gdansk, Lodz, Warsaw
- Age
- 18 years to 100 years
- People
- 710 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07665437 · EU 2025-523259-72-00 - Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Białystok, Chorzów, Cracow, Gdansk, Gdynia, Katowice, Lodz, Łódź, Lublin, Osielsko, Ostrowiec Świętokrzyski, Poznan, Pruszkow, Rzeszów, Skierniewice, Szczecin, Torun, Warsaw, Warszawa, Wroclaw
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 2Taking peopleBrivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Where
- Lodz, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Sanofi
See details and how to joinNCT07170917 · EU 2025-522333-61-00 - Phase 2Taking peopleA Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
- Where
- Ozarowice, Sosnowiec, Warsaw, Wroclaw
- Age
- 18 years to 65 years
- People
- 50 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07547813 · EU 2025-521865-29-00 - Phase 2Taking peopleA Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Where
- Katowice, Kielce, Ozarowice, Sosnowiec, Warsaw, Wroclaw
- Age
- 18 years to 70 years
- People
- 150 worldwide
- Run by
- Navigator Medicines, Inc.
See details and how to joinNCT07384975 · EU 2025-523557-33-00 - Phase 3Enrolling by invitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Bialystok, Chorzów, Gdansk, Katowice, Kielce, Krakow, Lodz, Lublin, Ossy, Poznan, Sosnowiec, Szczecin, Warsaw, Wroclaw
- Age
- 12 years and over
- People
- 835 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to joinNCT07007637 - Phase 2Taking peopleA Study of LAD191 in Adults With Hidradenitis Suppurativa
- Where
- Katowice, Łódź, Lublin, Sosnowiec, Warszawa, Wroclaw
- Age
- 18 years to 65 years
- People
- 200 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07151937 · EU 2025-521293-34-00